Related Experiment Video
Updated: Jul 6, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous
Tanja Rudolph1, Klaus-Peter Schaps, Daniel Steven
1Department of Cardiology, University Hospital Hamburg, Hamburg, Germany.
Insights
Interleukin-3 (IL-3) is elevated in coronary artery disease (CAD) patients, especially those undergoing angioplasty. Higher IL-3 levels predict restenosis, highlighting its role in chronic inflammation and atherosclerosis.
Area of Science:
- Immunology
- Cardiology
- Inflammation Research
Background:
- Interleukin-3 (IL-3) is synthesized by T-lymphocytes and implicated in chronic inflammation and atherosclerosis.
- Limited data exists on IL-3 levels in patients with coronary artery disease (CAD).
Purpose of the Study:
- To compare IL-3 concentrations in various CAD patient subsets and healthy controls.
- To investigate the association between IL-3 levels and restenosis after percutaneous coronary intervention.
Main Methods:
- Serum IL-3 and hs-CRP concentrations were measured in 205 CAD patients (stable angina, acute coronary syndrome, asymptomatic) and 41 controls.
- Measurements were taken at baseline and at 6 weeks, 6, and 12 months post-intervention.
- IL-3 levels were compared between groups and correlated with restenosis development.
Main Results:
- Detectable IL-3 levels were more frequent in patients undergoing coronary angioplasty compared to asymptomatic CAD or control groups (21% vs. 8% and 1%, respectively).
- Patients who developed symptomatic restenosis had significantly higher IL-3 levels than those without restenosis (45% vs. 17%).
- IL-3 emerged as the sole independent predictor of restenosis in multivariate analysis; hs-CRP was elevated in ACS but did not correlate with IL-3.
Conclusions:
- IL-3 is elevated in CAD patients, particularly those undergoing percutaneous coronary intervention.
- Elevated IL-3 concentrations are predictive of symptomatic restenosis.
- IL-3 plays a significant role in the inflammatory processes underlying CAD and restenosis.
Background:
Interleukin-3 (IL-3) synthesized by activated T-lymphocytes is a mediator in chronic inflammation and is suspected to promote atherosclerosis. Since there is no data on IL-3 in patients with coronary artery disease (CAD) available, we compared IL-3 concentrations in different subsets of patients with CAD to healthy control patients.
Methods:
205 consecutive patients with CAD, 136 with stable angina and 69 with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention, 61 patients with asymptomatic CAD and 41 patients with normal coronary arteries were investigated. Serum concentrations of IL-3 and hs-CRP were assessed at baseline and after 6 weeks, 6, and 12 months.
Results:
In patients undergoing coronary angioplasty, IL-3 was detectable more frequently than in those with asymptomatic CAD or without CAD, 21 vs. 8%, p=0.02, and 21 vs. 1%, p<0.001, respectively. Patients undergoing coronary angioplasty who developed symptomatic restenosis more frequently had detectable IL-3 levels than patients without restenosis, 45 vs. 17%, p=0.02. IL-3 was the only independent predictor for restenosis in a multivariate analysis. Hs-CRP was significantly elevated in patients with ACS, 230+/-170 mg/l vs. 100+/-140 mg/l, p=0.02, but did not correlate with IL-3 concentrations at any time.
Conclusion:
IL-3, an important regulator of chronic inflammation, is elevated in patients with CAD, particularly in symptomatic patients undergoing percutaneous coronary intervention. Furthermore, high IL-3 concentrations were found to be predictive of symptomatic restenosis.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Inflammatory Bowel Disease III: Crohn's Disease
Myocarditis III: Medical Management